Kuangli Bio-Tech Holdings CoTPE:6431 69 Current Ratio is 1.36 as of Dec. 2025, which is 28% below its 10-year median of 1.88. GuruFocus rates TPE:6431 with a GF Score™ of 69/100 and a GF Value™ of NT$11.73 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,985 Consumer Packaged Goods companies, Kuangli Bio-Tech Holdings Co ranks worse than 63.58% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Kuangli Bio-Tech Holdings Co's current ratio for the quarter that ended in Dec. 2025 was 1.36.
Kuangli Bio-Tech Holdings Co has a current ratio of 1.36. It generally indicates good short-term financial strength.
The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's Current Ratio or its related term are showing as below:
TPE:6431'
s Current Ratio Range Over the Past 10 Years
Min: 0.81 Med: 1.88 Max: 8.85
Current: 1.36
During the past 13 years, Kuangli Bio-Tech Holdings Co's highest Current Ratio was 8.85. The lowest was 0.81. And the median was 1.88.
TPE:6431's Current Ratio is ranked worse than 63.58% of 1985
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs TPE:6431: 1.36
Kuangli Bio-Tech Holdings Co (TPE:6431) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Kuangli Bio-Tech Holdings Co Current Ratio Related Terms
Kuangli Bio-Tech Holdings Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6431 vs PG, CL, KVUE: Current Ratio Comparison
For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kuangli Bio-Tech Holdings Co Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Kuangli Bio-Tech Holdings Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kuangli Bio-Tech Holdings Co (TPE:6431) has a Current Ratio of 1.36 as of Dec. 2025. This is 28% below median its historical median of 1.88. Over the past decade, Kuangli Bio-Tech Holdings Co's Current Ratio has ranged from 0.81 to 8.85. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1262 out of 1985 companies in the Consumer Packaged Goods industry, placing it in the top 63.6%.
Is Kuangli Bio-Tech Holdings Co's Current Ratio too high?
Kuangli Bio-Tech Holdings Co's current Current Ratio of 1.36 is 28% below median its 10-year median of 1.88. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 8.85. The Consumer Packaged Goods industry median Current Ratio is 1.73. Kuangli Bio-Tech Holdings Co's value of 1.36 is 21.4% below this industry median. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #1262 out of 1985 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's Current Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1262 out of 1985 companies for Current Ratio. This places Kuangli Bio-Tech Holdings Co in the lower half of its industry. The industry median Current Ratio is 1.73. Kuangli Bio-Tech Holdings Co's value of 1.36 is 21.4% below this benchmark. Historically, Kuangli Bio-Tech Holdings Co's own Current Ratio has ranged from 0.81 to 8.85 over the past decade. While the company's 10-year median is 1.88 vs. the industry median of 1.73, Kuangli Bio-Tech Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,985 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kuangli Bio-Tech Holdings Co's current Current Ratio of 1.36 is 21.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current Current Ratio is 1.36, which is 28% below median its own 10-year median of 1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.73, compared to a current price of NT$18.20 — trading 55.2% above its estimated fair value. The current Current Ratio is 1.36, which is 28% below median its 10-year median of 1.88 and 21.4% below the Consumer Packaged Goods industry median of 1.73. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current Current Ratio is 1.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued.
The current stock price of NT$18.20 is trading 55.2% above its estimated GF Value™ of NT$11.73.
GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.
Key valuation signals for TPE:6431:
Current Ratio: 1.36 (28% below median its 10-year median of 1.88)
GF Value™: NT$11.73 vs. price of NT$18.20 (55.2% above fair value)
Industry Position: 21.4% below the Consumer Packaged Goods median (#1262 of 1985)
No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
69GF Score
Get the complete analysis for TPE:6431
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6431 has been successfully added to your 
